Home
Spyre Therapeutics SYRE paid Arnold & Porter Kaye Scholer $40K for lobbying in Q1 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $40,000
- Quarter
- Q1 2026
- Client
- Spyre Therapeutics
- Reported
- 26/04/20
Up 300.0% from last quarter
What else happened in Spyre Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Spyre Therapeutics's other lobbying reports
- Spyre Therapeutics
LobbyingSpyre Therapeutics
LobbyingSpyre Therapeutics
SYRE
$10K
$10K
Reported 07/17
for Q2
- Spyre Therapeutics
LobbyingSpyre Therapeutics
LobbyingSpyre Therapeutics
SYRE
$10K
$10K
Reported 01/15
for Q4 2025